Answers are grounded in this paper and cite their sources.
cytotoxic T cells) returned to normal levels.2 In the two patients described by Clatworthy et al., the number of CD8+ T lymphocytes was low (190 and 80 cells per cubic millimeter; normal range, 200 to 900), but the number of CD19+ cells was within the normal range.Since alemtuzumab could eliminate about 77% of CD8+ T lymphocytes by means of non-complement-mediated mech an isms, 3 persistently suppressed CD8+ T cells could have influenced the development of anti-glomerular basement membrane antibodies in their patients.
No takes yet. Share an insight, caveat, or question.
Berger et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: